For press inquiries click here to contact us.
Relay Therapeutics
Scientists at the Movies: Relay Therapeutics CEO Sanjiv Patel on The Long Run
Element Biosciences
Ex-Illumina director’s rival startup Element raises $80M, hiring 100 people
Kinnate Biopharma
Kinnate jumps onto the biotech stage with $74.5M and a fledgling cancer drug pipeline
Venatorx Pharmaceuticals, Inc.
Malvern drugmaker is hopeful where others struggle: Fighting deadly ‘superbugs’
GenapSys
Biotech With iPad-Sized Gene Sequencer Gets Foresite-Led Funding
Turning Point Therapeutics
How Turning Point Therapeutics became a 2019 IPO standout
Lyell Immunopharma
Exclusive: GSK’s Hal Barron allies with Rick Klausner’s $600M cell therapy startup, looking to break new ground blitzing solid tumors
insitro
Coursera Cofounder Daphne Koller Melds AI And Biology In Drug Startup Insitro
Aimmune Therapeutics, Inc.
It’s not perfect, but it’s a good start: FDA panelists largely endorse Aimmune’s peanut allergy therapy
Please see important disclaimers in the Terms section.
